31
Iwashita Atsushi, Tachikawa Toshikazu: Negative resist material and method for forming resist pattern. Tokyo Ohka Kogyo, October 21, 2004: JP2004-294638 (53 worldwide citation)

PROBLEM TO BE SOLVED: To provide a negative resist material containing an acid generating agent and a polymer compound which is easily synthesized and has favorable storage stability and process stability by an alkali treatment, and to provide a method for forming a resist pattern.SOLUTION: The nega ...


32

33
Ding Qiang, Sim Tae Bo, Zhang Guobao, Adrian Francisco, Gray Nathanael S: Novel compounds and compositions as protein kinase inhibitors. Irm, Ding Qiang, Sim Tae Bo, Zhang Guobao, Adrian Francisco, Gray Nathanael S, GARRETT WACKOWSKI Eugenia, October 21, 2004: WO/2004/089286 (52 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated tyrosine kinase activity, particularly diseases associated with the activity ...


34
Leake Devin, Reynolds Angela, Khvorova Angela, Marshall William, Federov Yuriy, Nichols Kimberly: Modified polynucleotides for use in rna interference. Dharmacon, Leake Devin, Reynolds Angela, Khvorova Angela, Marshall William, Federov Yuriy, Nichols Kimberly, KALOW David A, October 21, 2004: WO/2004/090105 (49 worldwide citation)

Methods and compositions for performing RNA interference comprising a wide variety of stabilized siRNAs suitable for use in serum-containing media and for in vivo applications, such as therapeutic applications, are provided. These siRNAs permit effective and efficient applications of RNA interferenc ...


35
Mammen Mathai, Hughes Adam: Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity. Theravance, Mammen Mathai, Hughes Adam, HAGENAH Jeffrey A, October 21, 2004: WO/2004/089892 (46 worldwide citation)

This invention provides compounds of formula I: wherein R1, R2, R3, R4, R5, R6, R7, Ar1, Ar2, E, a, b, c, and z are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The compounds of this invention possess both &bgr;2 adrenergic receptor agoni ...


36
Shu Mark Cs: Heart valve prosthesis. Medtronic, Shu Mark Cs, LATHAM Daniel W, October 21, 2004: WO/2004/089246 (46 worldwide citation)

A heart valve prosthesis has a frame that includes at least one outwardly extending annular flange (48) adjacent to a suturing ring (10) and a band (12) comprising an inwardly extending annular flange (22) that is capable of engagement with the annular flange of the frame. A tortuous path is formed ...


37
Iwami Masashi, Doi Yoshiharu: Radio base station equipment, transmission directivity control method, and transmission directivity control program. Sanyo Electric, Sanyo Telecommunications, October 21, 2004: JP2004-297276 (46 worldwide citation)

PROBLEM TO BE SOLVED: To provide a radio base station equipment, a transmission directivity control method and a transmission directivity control program in which a desired wave and an interference wave can be separated accurately at an adaptive array terminal even when accurate control of the trans ...


38
Hörlin Ernst: Counter for counting doses. Ernst Hörlins Ingenjörsbyrå, Hörlin Ernst, ALBIHNS GÖTEBORG, October 21, 2004: WO/2004/089451 (45 worldwide citation)

The present invention relates to a counter for counting the number of doses delivered from a container, in which a dose, as a result of a usage motion, is delivered from the container by way of a delivery device and, upon which usage motion, the container moves in relation to the delivery device, wh ...


39
Bollbuck Birgit, Denholm Alastair, Eder Jörg, Hersperger René, Janser Philipp, Révész Lászlo, Schlapbach Achim, Wälchli Rudolf: Aminopyrimidine derivatives and their medical use. Novartis, Novartis Pharma Gmhbh, Bollbuck Birgit, Denholm Alastair, Eder Jörg, Hersperger René, Janser Philipp, Révész Lászlo, Schlapbach Achim, Wälchli Rudolf, GRUBB Philip, October 21, 2004: WO/2004/089913 (42 worldwide citation)

A compound of formula I or a pharmaceutically acceptable salt, ester or prodrug thereof wherein the variables haue the meanings as defined in the specification. Further disclosed are a method of inhibiting IKK activity using a compound of formula I, a method of inhibiting production of TNF using a c ...


40
Mikami Hiroshi, Nishida Akio: Combustion improving method of inflammable fuel in burning process of cement clinker. Ube, October 21, 2004: JP2004-292200 (42 worldwide citation)

PROBLEM TO BE SOLVED: To provide a combustion improving method of an inflammable fuel in the burning process of a cement clinker that suppresses elevation, lowering or variance of the combustion gas temperature and further prevents the damage of a kiln brick when inflammable wastes such as woods or ...